TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility GlobeNewswire November 13, 2025 MALVERN, Pa., Nov. 13, 2025 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the third quarter ended September 30, […]

Elicio Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates GlobeNewswire November 13, 2025 In the ongoing Phase 2 AMPLIFY-7P study evaluating ELI-002 7P in patients with pancreatic ductal adenocarcinoma (“PDAC”), fewer disease progressions and deaths than projected have been observed as of November 6, 2025. Based on 2:1 randomization with twice as

Fennec Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update GlobeNewswire November 13, 2025 ~ Q3 2025 Total Net Product Sales of $12.5 Million, 79% Year Over Year Growth ~ ~ Q3 2025 Positive Cash Flow from Operations, Cash Position Grew to $22 Million ~ ~ Japan Clinical Trial (STS-J01) Preliminary Results Expected

Amneal Receives U.S. FDA Approval for Iohexol Injection First-to-market complex injectable with expected launch in Q1 2026 GlobeNewswire November 13, 2025 BRIDGEWATER, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) — Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced the U.S. Food and Drug Administration (FDA) has approved the Company's iohexol injection (300 mg

Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress Conference call today, November 13, 2025, at 4:30 PM ET GlobeNewswire November 13, 2025 SAN DIEGO, Nov. 13, 2025 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the third quarter ended September 30, 2025. “Over the last year, we

Dare Bioscience Reports Third Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire November 13, 2025 DARE to PLAY(TM) Sildenafil Cream on Track to Launch Before Year End via 503B Pathway, Paving the Way for Near-Term Product Revenue Positive Interim DSMB Outcome for Ovaprene(R) Phase 3 Study Supports Continued Enrollment Multiple Grant-Funded Programs Advance, Including

NuCana Reports Third Quarter 2025 Financial Results and Provides Business Update GlobeNewswire November 13, 2025 Announced Encouraging Data on both NUC-7738 and NUC-3373 Initial Data from the Expansion Study of NUC-7738 Expected in Q4 2025 with Final Data Expected in 2026 Compliant with All Nasdaq Continued Listing Criteria Well Capitalized with Anticipated Cash Runway into

Collaborative Effort Demonstrates the use of Previous Generation Electric Vehicles and Bidirectional Charging Technologies within a Microgrid for Customer Cost Savings, Grid Support, and Energy Resilience Pacific Gas and Electric Company (PG&E), Nissan, and Fermata Energy are collaborating on a first-of-its-kind demonstration of automated frequency capabilities integrating electric vehicles and bi-directional chargers with a multi-customer

Shore Bancshares, Inc. (the “Company”) (NASDAQ: SHBI), the holding company for Shore United Bank, N.A. (the “Bank”), today announced the completion of its private placement of $60 million of its 6.25% Fixed to Floating Rate Subordinated Notes due 2035 (the “Notes”) to certain qualified institutional buyers and accredited investors. https://mma.prnewswire.com/media/803952/Shore_Bancshares_Logo.jpg The Notes will initially bear

ITC Holdings Corp. today announced the appointment of Diane Bridgewater and Rowena (Ro) Crosbie to its Board of Directors, Gabe Valle to vice president, deputy general counsel, and C. Patrick Woods to vice president, ITC Holdings Corp., president, ITC Great Plains, effective Jan. 1, 2026. https://mma.prnewswire.com/media/2822739/Diane_Bridgewater.jpg “Today's leadership appointments strengthen our ability to drive long-term